Found: 27
Select item for more details and to access through your institution.
Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: A cross sectional study.
- Published in:
- Life Science Alliance, 2022, v. 5, n. 12, p. 1, doi. 10.26508/lsa.202201479
- By:
- Publication type:
- Article
An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00648-4
- By:
- Publication type:
- Article
Virological and Clinical Determinants of the Magnitude of Humoral Responses to SARS-CoV-2 in Mild-Symptomatic Individuals.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.860215
- By:
- Publication type:
- Article
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and humoral responses against different variants of concern in domestic pet animals and stray cats from North‐Eastern Spain.
- Published in:
- Transboundary & Emerging Diseases, 2022, v. 69, n. 6, p. 3518, doi. 10.1111/tbed.14714
- By:
- Publication type:
- Article
Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 7, p. 1, doi. 10.1093/ofid/ofab329
- By:
- Publication type:
- Article
The Characteristics of the HIV-1 Env Glycoprotein Are Linked With Viral Pathogenesis.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.763039
- By:
- Publication type:
- Article
Anti-MPER antibodies with heterogeneous neutralization capacity are detectable in most untreated HIV-1 infected individuals.
- Published in:
- Retrovirology, 2014, v. 11, n. 1, p. 1, doi. 10.1186/1742-4690-11-44
- By:
- Publication type:
- Article
Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS‐CoV‐2 mRNA‐1237 vaccine in patients with solid tumors.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 4, p. 686, doi. 10.1002/1878-0261.13359
- By:
- Publication type:
- Article
Association between HIV replication and cholesterol in peripheral blood mononuclear cells in HIV-infected patients interrupting HAART.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 61, n. 2, p. 400
- By:
- Publication type:
- Article
Different Plasma Markers of Inflammation Are Influenced by Immune Recovery and cART Composition or Intensification in Treated HIV Infected Individuals.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0114142
- By:
- Publication type:
- Article
Expansion of antibody secreting cells and modulation of neutralizing antibody activity in HIV infected individuals undergoing structured treatment interruptions.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Expansion of antibody secreting cells and modulation of neutralizing antibody activity in HIV infected individuals undergoing structured treatment interruptions.
- Published in:
- Journal of Translational Medicine, 2012, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-48
- By:
- Publication type:
- Article
Demonstration of Antibodies Against SARS-CoV-2, Neutralizing or Binding, in Seroconversion Panels After mRNA-1273, BNT-162b2, and Ad26.COV2.S Vaccine Administration.
- Published in:
- Plasmatology, 2023, v. 17, p. 1, doi. 10.1177/26348535231202681
- By:
- Publication type:
- Article
Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motif.
- Published in:
- Scientific Reports, 2017, p. 40800, doi. 10.1038/srep40800
- By:
- Publication type:
- Article
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-81862-9
- By:
- Publication type:
- Article
Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46714-w
- By:
- Publication type:
- Article
Contribution of the HIV-1 Envelope Glycoprotein to AIDS Pathogenesis and Clinical Progression.
- Published in:
- Biomedicines, 2022, v. 10, n. 9, p. 2172, doi. 10.3390/biomedicines10092172
- By:
- Publication type:
- Article
Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1291972
- By:
- Publication type:
- Article
Glucocorticoids' treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patients.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-18996-x
- By:
- Publication type:
- Article
Role of Structured Treatment Interruption before a 5-Drug Salvage Antiretroviral Regimen: The Retrogene Study.
- Published in:
- Journal of Infectious Diseases, 2003, v. 188, n. 7, p. 977, doi. 10.1086/378411
- By:
- Publication type:
- Article
Efficacy of Low-Dose Subcutaneous Interleukin-2 to Treat Advanced Human Immunodeficiency Virus Type 1 in Persons with (less than or equal to) 250 mu L CD4 T Cells and Undetectable Plasma Virus Load.
- Published in:
- Journal of Infectious Diseases, 1999, v. 180, n. 1, p. 56, doi. 10.1086/314831
- By:
- Publication type:
- Article
Physicochemical characterization of the recombinant lectin scytovirin and microbicidal activity of the SD1 domain produced in rice against HIV-1.
- Published in:
- Plant Cell Reports, 2022, v. 41, n. 4, p. 1013, doi. 10.1007/s00299-022-02834-5
- By:
- Publication type:
- Article
Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIs.
- Published in:
- 2018
- By:
- Publication type:
- journal article
First Detection of SARS-CoV-2 Delta (B.1.617.2) Variant of Concern in a Dog with Clinical Signs in Spain.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 12, p. 2526, doi. 10.3390/v13122526
- By:
- Publication type:
- Article
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 6, p. 1135, doi. 10.3390/v13061135
- By:
- Publication type:
- Article
Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilities.
- Published in:
- Age & Ageing, 2022, v. 51, n. 5, p. 1, doi. 10.1093/ageing/afac101
- By:
- Publication type:
- Article
Gp120/CD4 Blocking Antibodies Are Frequently Elicited in ART-Naïve Chronically HIV-1 Infected Individuals.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0120648
- By:
- Publication type:
- Article